Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Trauner

Showing results (571-580 of 777) with videos related to

Pageof 78
Sort By:
Journal of Personalized Medicine|April 30, 2021
Influence of Genetic Variants on Disease Regression and Outcomes in HCV-Related Advanced Chronic Liver Disease after SVRGeorg Semmler, Teresa Binter, Karin Kozbial, et al.
Hepatology (Baltimore, Md.)|May 29, 2009
Side chain structure determines unique physiologic and therapeutic properties of norursodeoxycholic acid in Mdr2-/- miceEmina Halilbasic, Romina Fiorotto, Peter Fickert, et al.
Hepatology (Baltimore, Md.)|March 31, 2021
The Addition of C-Reactive Protein and von Willebrand Factor to Model for End-Stage Liver Disease-Sodium Improves Prediction of Waitlist MortalityPatrick Starlinger, Joseph C Ahn, Aidan Mullan, et al.
Journal of Hepatology|May 25, 2025
Enteronephrohepatic circulation of bile acids and therapeutic potential of systemic bile acid transporter inhibitorsAhmed Ghallab, Mattias Mandorfer, Guido Stirnimann, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 12, 2022
Age-adjusted mortality and predictive value of liver chemistries in a Viennese cohort of COVID-19 patientsLukas Hartl, Katharina Haslinger, Martin Angerer, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 25, 2022
Clinical significance of substantially elevated von Willebrand factor antigen levels in patients with advanced chronic liver diseaseKatharina Pomej, Bernhard Scheiner, Lorenz Balcar, et al.
JHEP Reports : Innovation in Hepatology|July 18, 2022
Risk of further decompensation/mortality in patients with cirrhosis and ascites as the first single decompensation eventLorenz Balcar, Marta Tonon, Georg Semmler, et al.
Cell Systems|June 18, 2018
Genetic Regulation of Plasma Lipid Species and Their Association with Metabolic PhenotypesPooja Jha, Molly T McDevitt, Emina Halilbasic, et al.
Gastroenterology|October 18, 2011
Alterations in lipid metabolism mediate inflammation, fibrosis, and proliferation in a mouse model of chronic cholestatic liver injuryTarek Moustafa, Peter Fickert, Christoph Magnes, et al.
United European Gastroenterology Journal|November 25, 2025
Alcohol Use After TIPS Implantation Significantly Increases the Risk of ACLF and Liver-Related DeathCaroline Schwarz, Andrea Kornfehl, Reema Abid, et al.
Pageof 78

Showing results (571-580 of 777) with videos related to

Sort By:
Pageof 78
Journal of Personalized Medicine|April 30, 2021
Influence of Genetic Variants on Disease Regression and Outcomes in HCV-Related Advanced Chronic Liver Disease after SVRGeorg Semmler, Teresa Binter, Karin Kozbial, et al.
Hepatology (Baltimore, Md.)|May 29, 2009
Side chain structure determines unique physiologic and therapeutic properties of norursodeoxycholic acid in Mdr2-/- miceEmina Halilbasic, Romina Fiorotto, Peter Fickert, et al.
Hepatology (Baltimore, Md.)|March 31, 2021
The Addition of C-Reactive Protein and von Willebrand Factor to Model for End-Stage Liver Disease-Sodium Improves Prediction of Waitlist MortalityPatrick Starlinger, Joseph C Ahn, Aidan Mullan, et al.
Journal of Hepatology|May 25, 2025
Enteronephrohepatic circulation of bile acids and therapeutic potential of systemic bile acid transporter inhibitorsAhmed Ghallab, Mattias Mandorfer, Guido Stirnimann, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 12, 2022
Age-adjusted mortality and predictive value of liver chemistries in a Viennese cohort of COVID-19 patientsLukas Hartl, Katharina Haslinger, Martin Angerer, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 25, 2022
Clinical significance of substantially elevated von Willebrand factor antigen levels in patients with advanced chronic liver diseaseKatharina Pomej, Bernhard Scheiner, Lorenz Balcar, et al.
JHEP Reports : Innovation in Hepatology|July 18, 2022
Risk of further decompensation/mortality in patients with cirrhosis and ascites as the first single decompensation eventLorenz Balcar, Marta Tonon, Georg Semmler, et al.
Cell Systems|June 18, 2018
Genetic Regulation of Plasma Lipid Species and Their Association with Metabolic PhenotypesPooja Jha, Molly T McDevitt, Emina Halilbasic, et al.
Gastroenterology|October 18, 2011
Alterations in lipid metabolism mediate inflammation, fibrosis, and proliferation in a mouse model of chronic cholestatic liver injuryTarek Moustafa, Peter Fickert, Christoph Magnes, et al.
United European Gastroenterology Journal|November 25, 2025
Alcohol Use After TIPS Implantation Significantly Increases the Risk of ACLF and Liver-Related DeathCaroline Schwarz, Andrea Kornfehl, Reema Abid, et al.
Pageof 78